Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

#A4502 · western blot

100
Citing papers
15.1k
Combined citations
Supplier page Find this product

Research areas

Gastrointestinal Tumor Research and Treatment37Sarcoma Diagnosis and Treatment19Gastrointestinal disorders and treatments10Cell Adhesion Molecules Research8Mast cells and histamine6Soft tissue tumor case studies6HER2/EGFR in Cancer Research5Metastasis and carcinoma case studies5

Papers citing this product

1
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
New England Journal of Medicine·2002·4.4k cit.·DOI
2
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
Clinical Cancer Research·2004·2.7k cit.·DOI
3
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants
Gastroenterology·2005·494 cit.·DOI
4
KIT Mutations Are Common in Incidental Gastrointestinal Stromal Tumors One Centimeter or Less in Size
American Journal Of Pathology·2002·444 cit.·DOI
5
KIT Mutations Are Common in Testicular Seminomas
American Journal Of Pathology·2004·319 cit.·DOI
6
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control
Immunity·2022·279 cit.·DOI
7
Prevalence of KIT Expression in Human Tumors
Journal of Clinical Oncology·2004·222 cit.·DOI
8
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type
Modern Pathology·2009·211 cit.·DOI
9
SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors
Modern Pathology·2010·210 cit.·DOI
10
Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study
BMC Cancer·2007·206 cit.·DOI